Search research articles
Contact Us
Filters
Showing results (201-210 of 204) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 204 results.
Chinese Medical Journal
|
October 30, 2024
Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial
Huiyun Zhu, Qian Xue, Yingxiao Song, et al.
ACS Sensors
|
April 20, 2026
Culture-Free Metabolic Labeling Analysis for Point-of-Care Antimicrobial Efficacy Evaluation of Tuberculosis
Guiqin Dai, Pengfei Zhao, Yang Zhou, et al.
Journal of Gastroenterology and Hepatology
|
September 13, 2018
The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome
Yinglian Xiao, Yuwen Li, Jianchang Shu, et al.
Alimentary Pharmacology & Therapeutics
|
May 4, 2022
The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study
Songfeng Chen, Deliang Liu, Honghui Chen, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 204) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 204 results.
Chinese Medical Journal
|
October 30, 2024
Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial
Huiyun Zhu, Qian Xue, Yingxiao Song, et al.
ACS Sensors
|
April 20, 2026
Culture-Free Metabolic Labeling Analysis for Point-of-Care Antimicrobial Efficacy Evaluation of Tuberculosis
Guiqin Dai, Pengfei Zhao, Yang Zhou, et al.
Journal of Gastroenterology and Hepatology
|
September 13, 2018
The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome
Yinglian Xiao, Yuwen Li, Jianchang Shu, et al.
Alimentary Pharmacology & Therapeutics
|
May 4, 2022
The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study
Songfeng Chen, Deliang Liu, Honghui Chen, et al.
Page
of 21